top of page

Your Partner in Strategic Innovation and Patient Delivery

Bringing products to patients through cutting-edge manufacturing technology and strategic sourcing expertise.

Group 1707482056 (1).png

Begin Optimizing Your Processes Today

researchers-protective-workwear-standing-laboratory-analyzing-liquid-samples-ion-chromatog
Logo and Name.png

About Engelex Consulting.

Engelex stands at the forefront of strategic sourcing and manufacturing technology consulting for cell and gene therapy. Our team of seasoned experts delivers innovative solutions that not only enhance productivity but also drive groundbreaking advancements in biotechnology firms worldwide. Partnering with Engelex transforms your challenges into opportunities and leads the way in delivering life-changing therapies to patients.

Our key Services.

Group 1707482057 (1) (2).png

Process Optimization

Maximizing output and robustness through phase-appropriate development and technology.

Strategic Sourcing

Building robust vein-to-vein supply chains that meet immediate and future manufacturing demands.

Group 1707482058 (1).png
Group 1707482059 (1).png

Technology Innovation

Integrating state-of-the-art technology into existing frameworks seamlessly.

Expertise

Discover cutting-edge solutions in manufacturing technology and capacity strategy with Engelex Consulting. Leveraging our cell and gene therapy native background, we provide data-driven insights that drive excellence and growth in the biotech sector.

Logo Only-Photoroom.png
image (1).jpg
  • Facebook - White Circle
  • LinkedIn - White Circle
  • Twitter - White Circle
two-scientists-looking-dna-strand 1.jpg

Our Commitment.

At Engelex Consulting, we are dedicated to increasing access to transformative cell and gene therapies by empowering our clients across the value chain with top-tier services and solutions. Our mission is to maximize the positive value our industry provides.

image.png
image (1).png
Group 1707482058 (2) (1).png
Group 1707482057 (1).webp
Vector.png

Contact us for more information about any of these CDMOs

Group 1707482059.png

CEO

Alex Klarer is an industry professional with a decade of experience in process development, CMC, manufacturing engineering, cGMP manufacturing, technology development, and business strategy. Alex has supported the design of pilot labs and cGMP spaces for a wide array cell and gene therapy applications.

Starting at Genentech, Alex focused on large-scale biologics production and later advanced cell therapy manufacturing at PCT (now Minaris Regenerative Medicine), leading programs for TCR-T and CRISPR-edited CAR-T therapies. As a founding team member of BioCentriq, Alex built the MS&T and technical operations groups. Following BioCentriq's acquisition by Green Cross Holdings, Alex transitioned into a corporate strategy role, accelerating growth through the launch of the LEAP™ Advanced Therapies Platform and establishing partnerships with technology developers.

Start Your Journey with Engelex

Begin Optimizing Your Processes Today

Supp_Macdonald_Lonza 1 (1).png
Group 1707482058 (3) (1) (1).png

Get in touch.

Thanks for your Message !

Banner_Trasparant (1).png

Begin Optimizing Your Processes Today

bottom of page